Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT07624916
Starting soon Phase 4

Transversus Abdominis Plane and Rectus Sheath Block for Robotic Colectomy

NCT07624916 · tracked via the Priya Life Science Taiwan tracker
Phase
Phase 4
Started
2026-06-01
Last updated
2026-06-03

Condition(s) studied

Rectus Sheath BlockTransversus Abdominis Plane BlockEnhanced Recovery After SurgeryRobotic SurgeryColorectal Cancer

Investigational drug(s) / intervention(s)

Ropivacaine →Saline

Ropivacaine: TAP+RS block using ropivacaine

Saline: TAP+RS block with saline

Study summary

This study aimed to evaluate the impact of ultrasound-guided bilateral transversus abdominis plane block combined with rectus sheath block on postoperative pain and recovery after robotic colectomy under an enhanced recovery after surgery (ERAS) protocol.

Eligibility

Sex
ALL
Min age
20 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Patients scheduled for elective robotic colorectal cancer surgery for the first time Exclusion Criteria: * Age \< 18 years or age \> 80 years * Allergic to any medication in the protocol * Infection over the injection site * Chronic pain history * Severe hepatic or renal insufficiency * Pregnancy * Emergency surgery * Refusal to join the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tri-Service General Hospital Taipei Taiwan

More Tri-Service General Hospital (TSGH) trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07624916 on ClinicalTrials.gov ↗ ← All trials in Taiwan